Ophthalmic Drugs Market Would Grow upto USD 49.73 million by 2030

Published August 28, 2023

Ophthalmic Drugs Market

Data Bridge Market Research has recently published a Report, titled, “Global Ophthalmic Drugs Market ” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape.

Data Bridge Market Research analyses a growth rate in the ophthalmic drugs market in the forecast period 2023-2030. The expected CAGR of ophthalmic drugs market is tend to be around 7.3% in the mentioned forecast period. The market is valued at USD 28.3 million in 2022, and it would grow upto USD 49.73 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-ophthalmic-drugs-market&Shri

Rise in incidence of eye disorders such as glaucoma and dry eye disease is pushing the market. As per the October 2021 report of World Health Organization on blindness and vision impairment, it is expected that nearly 2.2 billion people have distance or near vision impairment disorders. Increasing research and development activities and spending by major market players is likely to increase the ophthalmic drugs market growth during the forecast period 2023-2030. It was observed that the infection segment is expected to experience constant growth during the forecast period.

Market Overview:

Ophthalmic drugs are widely used to treat numerous eye diseases such as cataracts, diabetic retinopathy, glaucoma, and myopic choroidal. Some of the most prevalent eye diseases among children and adults are genetically determined. Ophthalmic drugs have been classified into anti-infective drugs, anti-glaucoma drugs, anti-VEGF agents, anti-inflammatory drugs, anti-allergy drugs, and others

Fundamental Aim of this Market Report

  • Factors influencing This Market Size and growth rate.
  • Major alterations to this market in the near future.
  • Notable Market rivals around the world.
  • Future Scope and Product Outlook
  • Future-promising emerging markets.
  • The Market Presents Difficult Challenges and Threats.


  • Increasing Research and Clinical Activities

Rising R&D activities and spending by major market players are expected to increase the growth of ophthalmic drugs during the projected period 2023-2030. For an instance, Alcon a leader in eye care spent USD 842 million on R&D in 2021 compared to USD 673 million in 2020. Alcon has an extensive range of products such as cataracts, contact lenses, and glaucoma products. Furthermore, increasing presence of a huge clinical drug process of promising candidates is likely to increase the market growth. For instance, Nicox, a novel eye therapeutics company has investigational candidate NCX 470- a novel NO donating PG analog is under its phase III trial and is anticipated to be marketed by 2029. Therefore, this factor increases the growth of the market.

  • Rising Demand of  Anti-VEGF Agents

The rising demand and wide adoption of anti-VEGF agents augment the increasing growth of the anti-VEGF agents segment. For instance, LUCENTIS manufactured by Genentech USA is a prescription medicine used for the treatment of patients suffering from diabetic retinopathy, AMD, and myopic choroidal neovascularization. Additionally, the growth of anti-VEGF agents is also due to the strong performance of Avastin, LUCENTIS, and others. The current class of anti-VEGF medications is very effective. Thus, this factor is boosting the growth of the market.

Recent Development

  • In 2022, Sandoz, a Novartis company, launched its generic combination eyedrop brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5%, an AB-rated generic equivalent to AbbVie’s COMBIGAN. It will help to lower eye pressure in patients suffering from ocular hypertension (high eye pressure) in the United States.
  • In 2022, Théa Pharma acquired seven branded ophthalmic products from Akorn Operating Company LLC. The deal supports Théa’s position as a major provider of products developed to satisfy the demands of eye care specialists across the U.S.

Key players operating in the ophthalmic drugs market include:

  • Akorn, Incorporated (U.S.)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Mitotech, SA (Germany)
  • AbbVie Inc. (U.S.)
  • Santen Pharmaceutical Co., Ltd (Japan).
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Bausch Health Companies Inc. (Canada.)
  • Novartis AG (Switzerland)
  • Merck & Co. Inc. (U.S.)
  • Bayer AG (Germany)
  • F. Hoffmann-La Roche Ltd (Switzerland)

To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@  https://www.databridgemarketresearch.com/reports/global-ophthalmic-drugs-market?Shri 

Ophthalmic Drugs Market Scope


  • Anti-Infective
  • Anti-fungal Drugs
  • Anti-bacterial Drugs
  • Others
  • Anti-Angiogenic
  • Anti-Inflammatory
  • NSAIDs
  • Steroids
  • Anti-Allergy
  • Anti-Vascular Endothelial Growth Factor
  • Anti-Glaucoma
  • Alpha Agonist
  • Beta Blockers
  • Prostaglandin Analogs
  • Combined Medication
  • Others
  • Others


  • Retinal Disorders
  • Eye Allergy
  • Dry Eye
  • Glaucoma
  • Uveitis
  • Eye Infection
  • Cataract
  • Others

Route of Administration

  • Topical
  • Systemic
  • Ocular
  • Others

End Users

  • Hospitals
  • Specialty Clinics
  • Others

Distribution Channel

  • Direct
  • Indirect

Key highlights of this Market report:

  • Growth rate
  • Remuneration prediction
  • Consumption graph
  • Market concentration ratio
  • Secondary industry competitors
  • Competitive structure
  • Major restraints
  • Market drivers
  • Regional bifurcation
  • Competitive hierarchy
  • Current market tendencies
  • Market concentration analysis

What benefits does the DBMR study is going to provide?

  • Latest industry influencing trends and development scenario
  • Open up New Markets
  • To Seize powerful market opportunities
  • Key decision in planning and to further expand market share
  • Identify Key Business Segments, Market proposition & Gap Analysis
  • Assisting in allocating marketing investments

Table of Contents:

  1. Introduction
  2. Market Segmentation
  3. Executive Summary
  4. Premium Insights
  5. Market Regulations
  6. Market Overview


Browse Detailed Summary of Research Report with TOC:  https://www.databridgemarketresearch.com/toc/?dbmr=global-ophthalmic-drugs-market&Shri

Key Benefits of the Report:

  • This study presents the analytical depiction of this industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of this market share.
  • The current market is quantitatively analyzed to highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed this industry analysis based on competitive intensity and how the competition will take shape in the coming years.

Top DBMR Healthcare Reports:        







About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Email:- corporatesales@databridgemarketresearch.com

CDN Newswire